The tweet was deleted by the author.
But we saved everything 🙂.
NovoCure Ltd published its financial outcomes for the first quarter ending March 31, 2026.
The company announced its results through a press release, offering key updates on its business and financial standing for the period. Investors and analysts can review the complete details via the provided company link. Details regarding specific revenue, profit metrics, or forward guidance were not included in this communication. Updates may follow as more information becomes available.
NovoCure had previously scheduled the release of its first quarter 2026 financial results for April 30, according to a company statement. The announcement followed earlier communications setting expectations for the timing of its financial disclosures. No further details on the reported metrics were made available at this stage.